Qvintip® is an at-home, easy-to-use, self-test solution for Human Papillomavirus (HPV) enabling early detection of risk for cervical cancer with the same accuracy as sampling performed at a clinic. The device allows women to collect a vaginal fluid sample for lab analysis in the comfort of their own home.

Qvintip has unsurpassed 17 years of clinical validation and feasibility trials in 12 countries across the globe. It has been validated against clinically collected cervical samples in multiple studies and it is now used in clinical practice of primary HPV screening. From independent research it has been shown that women prefer Qvintip over other self-sampling devices.